Sign In
Buy NDAQ
$82.49
-0.120 (-0.145%)
At Close: Jun 23, 2026
NDAQ Hits 52-Week High, Trades at a Discount: How to Play the Stock
10:31am, Monday, 09'th Jun 2025
Nasdaq is set to grow on its increasing on-trading revenue base, impressive organic growth and investments in proprietary data, supported by a solid capital position.
ScanTech AI Systems Appoints Security Industry Veteran Brad Buswell as Chairman of the Board
09:27am, Monday, 09'th Jun 2025
Leadership Transition Strengthens Board Oversight and Strategic Alignment Following Nasdaq Listing Leadership Transition Strengthens Board Oversight and Strategic Alignment Following Nasdaq Listing
Nasdaq Grants AGM Group Holdings Inc. Continued Listing on The Nasdaq Stock Market Subject to Conditions
08:30am, Monday, 09'th Jun 2025
Beijing, June 09, 2025 (GLOBE NEWSWIRE) -- AGM Group Holdings Inc. (“AGM Holdings” or the “Company”) (NASDAQ: AGMH), an integrated technology company specializing in the assembling and sales o
Prediction: 2 Nasdaq Stocks Will Be Worth More Than Palantir Technologies in 3 Years
03:55am, Sunday, 08'th Jun 2025
Palantir Technologies stock has advanced 435% in the past year, bringing its market value to $300 billion as of June 7. But two Nasdaq stocks, Shopify (SHOP 6.17%) and Intuitive Surgical (ISRG -0.19%)
QQA: New Option Strategy ETF In The Nasdaq 100
11:11am, Saturday, 07'th Jun 2025
The Invesco QQQ Income Advantage ETF offers an 8.63% yield from option strategies in the Nasdaq 100. QQA has 3/4 of assets in Nasdaq 100 stocks and delegates option income generation to equity-linked
The Nasdaq Bounces Back: 2 Artificial Intelligence (AI) Stocks Worth Buying Right Now
07:30am, Saturday, 07'th Jun 2025
Technology stocks are surging once again, especially artificial intelligence stocks. But don't think it's too late to buy in.
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:30pm, Friday, 06'th Jun 2025
SAN DIEGO--(BUSINESS WIRE)--Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pul
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:44pm, Friday, 06'th Jun 2025
MIAMI--(BUSINESS WIRE)---- $SMMT--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of
iOThree Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
04:30pm, Friday, 06'th Jun 2025
Singapore, June 06, 2025 (GLOBE NEWSWIRE) -- iOThree Limited ("iOThree" or the "Company") (NASDAQ: IOTR), a leading provider of maritime digital technologies including satellite connectivity and digit
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 06'th Jun 2025
CAMBRIDGE, Mass., June 06, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives o
BloomZ Granted 180 Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
04:05pm, Friday, 06'th Jun 2025
TOKYO, JAPAN / ACCESS Newswire / June 6, 2025 / BloomZ Inc. (NASDAQ:BLMZ) ("BloomZ" or the "Company"), a Japanese audio production, VTuber, entertainment, and voice actor management company, announced
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Friday, 06'th Jun 2025
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercializat
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:00pm, Friday, 06'th Jun 2025
WESTLAKE VILLAGE, Calif., June 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in
Omada Health IPO: CEO explains why the digital health company went public now
01:32pm, Friday, 06'th Jun 2025
Telehealth provider Omada Health raised $150 million in its IPO as the company makes its public debut on the Nasdaq on Friday. Omada Health CEO Sean Duffy sits down with Yahoo Finance senior health re
Venus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
11:35am, Friday, 06'th Jun 2025
$1.15 million upfront with up to an additional $2.3 million of potential aggregate gross proceeds upon the exercise in full of unregistered short-term warrants $1.15 million upfront with up to an addi
